Perform Another (Advanced) Search

1.  CenterWatch: New Medical Therapies in Disease Category (332), Systemic Candidiasis
...CenterWatch: New Medical Therapies in Disease Category (332), Systemic Candidiasis Systemic Candidiasis Patient Medical Areas • Immunology/Infectious Diseases October 15, 2007 Merck announced positive interim results from ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (495), Oral Candidiasis
...CenterWatch: New Medical Therapies in Disease Category (495), Oral Candidiasis Oral Candidiasis Patient Medical Areas • Immunology/Infectious Diseases • Otolaryngology October 15, 2007 Merck announced positive interim results ...
View Page

3.  CenterWatch: New Medical Therapies in Disease Category (466), Candidemia/Candidiasis
...CenterWatch: New Medical Therapies in Disease Category (466), Candidemia/Candidiasis Candidemia/Candidiasis Patient Medical Areas • Hematology • Immunology/Infectious Diseases February 14, 2005 Vicuron Pharmaceuticals reported positive results ...
View Page

4.  CenterWatch: New Medical Therapies in Disease Category (178), Cutaneous Candidiasis
...CenterWatch: New Medical Therapies in Disease Category (178), Cutaneous Candidiasis Cutaneous Candidiasis Patient Medical Areas • Immunology/Infectious Diseases January 13, 2003 Versicor reported positive results from a ...
View Page

5.  CenterWatch: Clinical Trials in Category (466) Candidemia/Candidiasis
...CenterWatch: Clinical Trials in Category (466) Candidemia/Candidiasis Candidemia/Candidiasis State • New Jersey New Jersey Morristown : Atlantic Health System Study to Compare the Efficacy and ...
View Page

6.  CenterWatch: Clinical Trials in Category (178) Cutaneous Candidiasis
...CenterWatch: Clinical Trials in Category (178) Cutaneous Candidiasis Cutaneous Candidiasis Country • [X]   France • [X]   Italy France Paris Cedex 10 : Hôpital Saint-Louis If you have ...
View Page

7.  Study Posting (5359) Trial #155050, Candidemia/Candidiasis, West Reading, PA
...Study Posting (5359) Trial #155050, Candidemia/Candidiasis, West Reading, PA Trial Information If you or someone you know is in the hospital with Candidemia or Invasive Candidiasis. If so, please contact Crystal Nagle at 610-988-4308 and see if this study ...
View Page

8.  Study Posting (1570) Trial #156498, Candidemia/Candidiasis, Morristown, NJ
...Study Posting (1570) Trial #156498, Candidemia/Candidiasis, Morristown, NJ Trial Information Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis The study will evaluate how effective and how safe the drug micafungin is when compared ...
View Page

9.  CenterWatch New Medical Therapies™ in Immunology/Infectious Diseases
...Acute Rhinitis AIDS and AIDS related infections Allergies & Asthma Allergy Atopic Dermatitis Bacterial Infections Candidemia/Candidiasis Canker Sores Celiac Disease Cervical Dysplasia Chronic Fatigue Syndrome Clostridium Difficile-Associated Diarrhea Cold Sores (Herpes Labialis Infections) Common Cold Conjunctivitis, Bacterial COPD (Chronic Obstructive Pulmonary Disease) Cutaneous Candidiasis Cutaneous Lupus Erythematosus Cutaneous T-Cell Lymphoma Cytomegalovirus Infections Fever Genital Herpes Genital Warts Graft ...
View Page

10.  CenterWatch: New Medical Therapies in Disease Category (232), Aspergillosis
...non-comparative study enrolled subjects aged three months to 17 years with invasive aspergillosis, esophageal candidiasis or invasive candidiasis. The subjects received Cancidas at 50 mg/m(2) daily (maximum 70 mg daily) following ...
View Page

11.  Study Posting (4000) Trial #114684, Cutaneous Candidiasis, Turin, Italy
...Study Posting (4000) Trial #114684, Cutaneous Candidiasis, Turin, Italy Trial Information If you have mycosis fungoides type CTCL and have experienced treatment ...
...with systemic or skin directed treatments you may be eligible for this clinical trial. Cutaneous Candidiasis Turin, Italy 114684 Clinical Trial Participation If you would like to learn more about participating ...
View Page

12.  Study Posting (4000) Trial #114686, Cutaneous Candidiasis, Pierre Bénite, France
...Study Posting (4000) Trial #114686, Cutaneous Candidiasis, Pierre Bénite, France Trial Information If you have mycosis fungoides type CTCL and have experienced ...
...with systemic or skin directed treatments you may be eligible for this clinical trial. Cutaneous Candidiasis Pierre Bénite, France 114686 Clinical Trial Participation If you would like to learn more about ...
View Page

13.  Study Posting (4000) Trial #114685, Cutaneous Candidiasis, Paris Cedex 10, France
...Study Posting (4000) Trial #114685, Cutaneous Candidiasis, Paris Cedex 10, France Trial Information If you have mycosis fungoides type CTCL and have ...
...with systemic or skin directed treatments you may be eligible for this clinical trial. Cutaneous Candidiasis Paris Cedex 10, France 114685 Clinical Trial Participation If you would like to learn more ...
View Page

14.  CenterWatch: New Medical Therapies in Disease Category (249), Yeast Infections
...positive results of a phase III trial of anidulafungin , for the treatment of hospital acquired candidiasis/candidemia. Study data exceeded their primary endpoint of non-inferiority, establishing statistically superior global response ...
...n=52/118). This randomized, double-blind, multi-center study enrolled 256 subjects with invasive candidiasis/candidemia, who received daily doses of either 100 mg anidulafungin or 400 mg fluconazole for ...
View Page

15.  CenterWatch: Clincial Trial Listings in Immunology/Infectious Diseases
...Asthma   (20, 7 New! ) Allergy   (49, 1 New! ) Atopic Dermatitis   (6) Bacterial Infections   (1) Candidemia/Candidiasis   (1) Celiac Disease   (24) Cervical Dysplasia   (21) Chronic Fatigue Syndrome   (2) Clostridium Difficile-Associated Diarrhea ...
...6) Conjunctivitis, Bacterial   (8, 2 New! ) COPD (Chronic Obstructive Pulmonary Disease)   (140, 5 New! ) Cutaneous Candidiasis   (3) Cutaneous T-Cell Lymphoma   (22) Cytomegalovirus Infections   (103, 1 New! ) Fever   (1) Genital Herpes ...
View Page

16.  CenterWatch New Medical Therapies™ in Otolaryngology
...Otolaryngology Otolaryngology Acute Rhinitis Allergies & Asthma Allergy Aspergillosis Auditory Loss and Deafness Esophageal Cancer Oral Candidiasis Otitis Media Pharyngitis Pneumonia Sinus Infections Strep Throat Jobson Medical Information • Privacy | • Glossary Copyright © 1995 ...
View Page

17.  CenterWatch New Medical Therapies™ in Hematology
...Hematology Hematology Acute Myelogenous Leukemia (AML) Anemia Blood Clots Blood Transfusions Bone Marrow Transplant Candidemia/Candidiasis Chronic Renal Anemia Gaucher Disease Hematologic Cancer Hemoglobinuria, Paroxysmal Hemophilia Hemorrhages Idiopathic Thrombocytopenic Purpura (ITP ...
View Page

18.  Newly Approved Drug Therapies (899) Eraxis (anidulafungin), Pfizer,
...of fungal infections: Candidemia; intra-abdominal abscess and peritonitis caused by Candida species; and esophageal candidiasis. The drug has not been studied for the treatment of Candida related endocarditis, osteomyelitis, or ...
...observed (generally through at least 14 days after the last positive fungal culture). For esophageal candidiasis, recommended dosing is a single loading dose of 100 mg on day 1, followed by ...
View Page

19.  CenterWatch: Clincial Trial Listings in Hematology
...Blood Clots   (1) Blood Transfusions   (2, 2 New! ) Bone Marrow Transplant   (19, 3 New! ) Candidemia/Candidiasis   (1) Hematologic Cancer   (22, 6 New! ) Hematologic Neoplasms   (22) Hematological Disorders   (20, 2 New! ) Hemodialysis ...
View Page

20.  Newly Approved Drug Therapies (239) SPORANOX (itraconazole), Janssen Pharmaceutica,
...current front-line therapy in healing the white plaques and raw, ulcerated lesions associated with candidiasis. Data presented at the 11th International Conference on AIDS in Vancouver in July, comparing SPORANOX ...
...Similar results were found in a double-blind randomized study of 119 patients with esophageal candidiasis. An average of 86% of patients were cured or improved with 100 mg/day of ...
View Page